Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT06777420

Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy

Led by Region Örebro County · Updated on 2025-04-20

218

Participants Needed

3

Research Sites

100 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Preoperative chemotherapy has been shown to be at least as effective as postoperative chemotherapy in breast cancer patients and has seen increased use over time. The decision regarding neoadjuvant treatment is complex, as various aspects need to be considered, and the patient's role in the decision-making process is central. The information provided by doctors to patients about preoperative treatment can be complicated, including details about treatment options, treatment plans, and side effects. If this information is not conveyed adequately, there is a risk of misunderstandings, which can lead to increased anxiety and stress for patients regarding their decisions. In oncology, question prompt lists (QPL) have been used as a tool to support patients by improving the information conveyed by doctors in various contexts where complex decisions need to be made. Studies have shown that QPL can facilitate better information exchange. However, their use in discussions about preoperative treatment for breast cancer patients has not been studied. Furthermore, evidence from randomized studies on the use of QPL in clinical practice is very limited. The aim of this study is to investigate whether the use of QPL during patient consultations involving discussions about neoadjuvant chemotherapy can improve information exchange in various aspects: understanding of the treatment; anxiety about the decision; participation in the decision-making process; patient-doctor communication; and decision-related conflict.

CONDITIONS

Official Title

Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with operable breast cancer eligible for systemic neoadjuvant therapy according to current guidelines
Not Eligible

You will not qualify if you...

  • Patients with locally advanced breast cancer where neoadjuvant therapy is mandatory
  • Patients with cognitive impairment assessed by their physician as unable to participate
  • Patients who cannot speak or read Swedish or English

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Akademiska Uppsala University Hospital

Uppsala, Region Uppsala, Sweden

Not Yet Recruiting

2

Västerås General Hospital

Västerås, Region Västmanland, Sweden

Not Yet Recruiting

3

Örebro University Hospital

Örebro, Sweden, 70185

Actively Recruiting

Loading map...

Research Team

A

Antonios Valachis, MD, PhD

CONTACT

S

Servah Hosseini, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here